Cortical allograft as a vehicle for antibiotic delivery

Acta Orthopaedica

Volumn 76, Issue 4, 2005, Pages 481-486

  Witsø, Eivind ^a   Persen, Leif ^a   Benum, Pål ^a   Bergh, Kåre ^a,b  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; NETILMICIN; RIFAMPICIN; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL GROWTH; BONE ALLOGRAFT; CONTROLLED STUDY; CORTICAL BONE; DRUG DELIVERY SYSTEM; HUMAN; HUMAN TISSUE; IN VIVO STUDY; MALE; NONHUMAN; RAT; STAPHYLOCOCCUS AUREUS; SURGICAL INFECTION;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; BONE TRANSPLANTATION; FEMUR; NETILMICIN; POSTOPERATIVE COMPLICATIONS; RATS; RATS, WISTAR; RIFAMPIN; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TRANSPLANTATION, HOMOLOGOUS; VANCOMYCIN;

EID: 24144433806     PISSN: 17453674     EISSN: None     Source Type: Journal    
DOI: 10.1080/17453670510041457     Document Type: Article

References (27)

1. Andersen B M, Bergh K, Steinbakk M, Syvertsen G, Magnaes B, Dalen H, Bruun J N. A Norwegian nosocomial outbreak of methicillin-resistant Staphylococcus aureus resistant to fusidic acid and susceptible to other antistaphylococcal agents. J Hosp Infect 1999; 41 (2): 123-32.
2. Aro H T, Aho A J. Clinical use of bone allografts. Ann Med 1993; 25: 403-12.
3. Buttaro M A, Della Valle A M G, Piñero L, Mocetti E, Moranidi A A, Piccaluga F. Incorporation of vancomycin-supplemented bone allografts. Radiographical, histopathological and immunohistochemical study in pgs. Acta Orthop Scand 2003; 74: 505-13
4. Deijkers R L M, Bloem R M, Petit P L C, Brand R, Vehmyer S B W, Veen M R. Contamination of bone allograft. Analysis of incidence and predisposing factors. J Bone Joint Surg (Br) 1997; 79 (1): 161-6.
5. Drancourt M, Stein A, Argenson J N, Zannier A, Curvale G, Raoult D. Oral rifampicin plus oxfloxacin for treatment of Staphylococcus-infected orthopaedic implants. Antimicrob Agents Chemother 1993; 37 (6): 1214-8.
6. Gray J C, Elves M W. Osteogenesis in bone grafts after short-term storage and topical antibiotic treatment. An experimental study in rats. J Bone Joint Surg (Br) 1981; 63 (3): 441-5.
7. Gristina A G, Jennings R A, Naylor P T, Myrvik Q N, Webb L. Comparative in vitro antibiotic resistance of surface-colonizing coagulase-negative staphylococci. Antimicrob Agents Chemother 1989; 33: 813-6.
8. Gross A E, Hutchison C R, Alexeeff M, Mahomed N, Leitch K, Morsi E. Proximal femoral allografts for reconstruction of bone stock in revision arthroplasty of the hip. Clin Orthop 1995; (319): 151-8.
9. Haddad F S, Spangehl M J, Masri B A, Garbutz D S, Duncan C P. Circumferential allograft replacement of the proximal femur. Clin Orthop 2000; (371): 98-107.
10. Hirn M Y J, Salmela M, Vuento R E. High-pressure saline washing of allografts reduces bacterial contamination. Acta Orthop Scand 2001; 72 (1): 83-5.
11. Hope P G, Kristinsson K G, Norman P, Elson R A. Deep infection of cemented total hip arthroplasties caused by coagulase-negative staphylococci. J Bone Joint Surg (Br) 1989; 71 (5): 851-5.
12. Huddleston P M, Steckelberg J M, Hanssen A D, Rouse M S, Bolander M E, Patel R. Ciprofloxacin inhibition of experimental fracture-healing. J Bone Joint Surg (Am) 2000; 82 (2): 161-73.
13. Journeaux S F, Johnson N, Bryce S L, Friedman S J, Sommerville S M M, Morgan D A F. Bacterial contamination rates during bone allograft retrieval. J Arthroplasty 1999; 14 (6): 677-81.
14. Lindsey R W, Probe R, Miclau T, Alexander J W, Perren M P. The effects of antibiotic-impregnated autogenic cancellous bone graft on bone healing. Clin Orthop 1993; (291): 303-12.
15. Lord C F, Gebhardt M C, Tomford W W, Mankin H J. Infection in bone allografts. J Bone Joint Surg (Am) 1988; 70: 369-76.
16. Miclau T, Edin M L, Lester G E, Lindsey R W, Dahners L E. Bone toxicity of locally applied aminoglycosides. J Orthop Trauma 1995; 9 (5): 401-6.
17. Ozaki T, Hillmann A, Bettin D, Wuisman P, Winkelmann W. Intramedullary, antibiotic-loaded cemented, massive allografts for skeletal reconstruction. Acta Orthop Scand 1997; 68 (4): 387-91.
18. Parrish F F. Allograft replacement of all or part of the end of a along bone following excision of a tumor. Report of twenty-one cases. J Bone Joint Surg (Am) 1973; 55 (1): 1-22.
19. Petri W H. Osteogenic activity of antibiotic-supplemented bone allografts in the Guinera pig. J Oral Maxillofac Surg 1984; 42 (10): 631-6.
20. Sorger J I, Hornicek F J, Zavatta M, Menzner J P, Gebhardt M C, Tomford W W, Mankin H J. Allograft fractures revisited. Clin Orthop 2001; (382): 66-74.
21. Tomford W W, Thongphasuk J, Mankin H J, Ferraro M J. Frozen musculoskeletal allografts. A study of the clinical incidence and causes of infection associated with their use. J Bone Joint Surg (Am) 1990; 72: 1137-43.
22. Webb L X, Holman J, Araujo B de, Zaccaro D J, Gordon E S. Antibiotic resistance in staphylococci adherent to cortical bone. J Orthop Trauma 1994; 8 (1): 28-33.
23. Winkler H, Janata O, Berger C, Wein W, Georgopoulos A. In vitro release of vancomycin and tobramycin from impregnated human and bovine bone grafts. J Antimicrob Chemot 2000; 46: 423-8.
24. Witsø E, Persen L, Benum P, Bergh K. Release of netilmicin and vancomycin from cancellous bone. Acta Orthop Scand 2002; 73 (2): 199-205.
25. Witsø E, Persen L, Benum P, Aamodt A, Schnell Husby O, Bergh K. High local concentrations without systemic adverse effects after impaction of netlimicin-impregnated bone. Acta Orthop Scand 2004; 75 (3): 339-46.
26. Zimmerli W, Frei R, Widmer A F, Rajacic Z. Microbiological tests to predict treatment outcome in experimental device-related infections due to Staphylococcus aureus. J Antimicrob Chemother 1994; 33: 959-67.
27. Zimmerli W, Widmer A F, Blatter M, Frei R, Ochsner P E. Role of rifampicin for treatment of orthopaedic implant-related staphylococcal infections. JAMA 1998; 279 (19): 1537-41.